Please login to the form below

Not currently logged in

Ferring agrees Chinese reproductive medicine research deal

Work with the Chinese Academy of Sciences on the long-term project


Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) are set to collaborate on a long-term project to advance basic and translational research in reproductive medicine.

The project will see the duo develop novel product candidates and therapeutic strategies in a jointly funded laboratory based in the CAS research facility in Beijing, China.

Known as the ‘Ferring Institute of Reproductive Medicine’, the facility will bring together researchers from both Ferring and CAS to find solutions that will address global challenges in fertility and high rates of obstetric complications.

Per Falk, executive vice president and chief scientific officer of Ferring Pharmaceuticals, said: “Across the world too many couples still face considerable challenges when trying to become families.

“This collaboration forms the next phase in our ongoing effects to advance knowledge and care in reproductive medicine and women’s health.”

The pharmaceutical group has said that they hope to gain a deeper understanding of fertility and implantation, with the aim of discovering new solutions.

Professor Hongemi Wang, director of the state key laboratory, CAS, said: “Our collaboration with Ferring will expand our research base into the translational space and together we will rapidly expand our tool set to look at truly transformational ideas in reproductive medicines.”

CAS has an additional interest in the collaboration, as it will provide expertise and funding to support their stem cell research and regenerative medicine, a core element of their Innovation 2030: Building Tomorrow initiative, which aims to improve reproductive health both in China and worldwide.

Article by
Gemma Jones

12th January 2018

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...